<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Enbrel preparations; Etanercept: rheumatic diseases" /><meta name="IX" content="Enbrel preparations; Etanercept: rheumatic diseases" /><title>Enbrel®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="128237.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="128237.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=128237.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2077.htm">10 Musculoskeletal and joint diseases</a> &gt; <a href="5182.htm">10.1 Drugs used in rheumatic diseases and gout</a> &gt; <a href="5288.htm">10.1.3 Drugs that suppress the rheumatic disease process</a> &gt; <a href="202659.htm">Cytokine modulators</a> &gt; <a href="128236.htm">ETANERCEPT</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="204103.htm" title="Previous: CERTOLIZUMAB PEGOL">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="212247.htm" title="Next: GOLIMUMAB">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a300031.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Etanercept</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Disease-modifying Antirheumatic Drugs 92:36</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20283-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Etanercept</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: E &gt; Interactions of Etanercept</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="202659.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cytokine modulators</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases and gout &gt; 10.1.3 Drugs that suppress the rheumatic disease process</p></div></li><li><a href="128236.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ETANERCEPT</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases and gout &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Cytokine modulators</p></div></li><li><a href="106473.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">13.5.3 Drugs affecting the immune response</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 13 Skin &gt; 13.5 Preparations for eczema and psoriasis</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22etanercept%22%22etanercept%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/128229.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cytokine modulators</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/128236.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ETANERCEPT</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response &gt; Cytokine modulators</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/128237.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Enbrel®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response &gt; Cytokine modulators &gt; ETANERCEPT</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22etanercept%22%22etanercept%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c62-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Etanercept</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; E</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/e13-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Etanercept</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; E</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20283-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Etanercept</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Analgesics Anti-inflammatory Drugs and Antipyretics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/03712.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Etanercept</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; E &gt; ET</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D664.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Etanercept</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; E</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_128236">ETANERCEPT</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i992.htm" title="Go to appendix 1">Etanercept</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF"> see under <a title="BNF:target-block: Etanercept-arthritis" href="202659.htm#_208117">Cytokine Modulators</a> above</p></div><div class="cAF" id="_201656"><h2>Cautions</h2> <p class="cAF">predisposition to infection (avoid if predisposition to septicaemia); significant
exposure to herpes zoster virus—interrupt treatment
and consider varicella–zoster immunoglobulin; hepatitis
B virus—monitor for active infection; monitor
for worsening hepatitis C infection; children should
be brought up to date with current immunisation schedule (<a title="BNF:topic: Immunisation schedule" href="38311.htm#_38311">section 14.1</a>) before initiating therapy; heart failure (risk of exacerbation); history or increased
risk of demyelinating disorders; history or development of malignancy; monitor for skin cancer before and during treatment, particularly
in those at risk (including patients with psoriasis or a history of
PUVA treatment); history of blood disorders; diabetes mellitus; <b>interactions:</b> Appendix 1 (etanercept)</p><div class="cAV"><h3>Tuberculosis</h3> <p class="cAX">Patients should be evaluated
for tuberculosis before treatment. Active tuberculosis
should be treated with standard treatment (<a title="sub-section: Antituberculous drugs" href="3899.htm#_3899">section 5.1.9</a>) for at least 2 months before
starting etanercept. Patients who have previously received
adequate treatment for tuberculosis can start etanercept but should
be monitored every 3 months for possible recurrence. In patients without active tuberculosis but who were previously not
treated adequately, chemoprophylaxis should ideally be completed before
starting etanercept. In patients at high
risk of tuberculosis who cannot be assessed by tuberculin skin test,
chemoprophylaxis can be given concurrently with etanercept. Patients should be advised to seek medical attention
if symptoms suggestive of tuberculosis (e.g. persistent cough, weight
loss, and fever) develop</p></div><div class="cAV"><h3>Blood disorders</h3> <p class="cAX">Patients should be
advised to seek medical attention if symptoms suggestive of blood
disorders (such as fever, sore throat, bruising, or bleeding) develop</p></div></div><div class="cAF" id="_201657"><h2>Contra-indications</h2> <p class="cAF">active infection; avoid injections containing benzyl alcohol in neonates (see preparations below)</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">use with caution in moderate to severe alcoholic hepatitis</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">avoid—limited information available; manufacturer
advises effective contraception required during treatment and for
3 weeks after last dose</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">manufacturer advises avoid—present in milk in <i>animal</i> studies</p></div><div class="cAF" id="_201658"><h2>Side-effects</h2> <p class="cAF">see under <a title="BNF:target-block: Cytokine inhibitor side-effects notes 10.1.3" href="202659.htm#_200785">Cytokine Modulators</a>; also <i>less commonly</i> interstitial lung disease,
skin cancer, uveitis, rash, new onset or worsening psoriasis; <i>rarely</i> demyelinating disorders, seizures, lymphoma, Stevens-Johnson
syndrome, vasculitis; <i>very rarely</i> toxic epidermal
necrolysis; <i>also reported</i> appendicitis, gastritis,
oesophagitis, inflammatory bowel disease, vomiting, diabetes mellitus,
malignancy (including solid tumours and leukaemia), macrophage activation
syndrome, and cutaneous ulcer</p></div><div class="cAF"><h2>Dose</h2> <p class="cR"><span class="cU">By subcutaneous injection</span>, rheumatoid
arthritis, psoriatic arthritis, ankylosing spondylitis, <span class="cAK">adult</span> over 18 years, 25 mg twice weekly <i>or</i> 50 mg once weekly</p><p class="cS">Active polyarticular juvenile idiopathic arthritis, <span class="cAK">child</span> 2–17 years, 400 micrograms/kg (max. 25 mg)
twice weekly, with an interval of 3–4 days between doses; consider
discontinuation if no response after 4 months</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_128237" style="margin: 0 0 0 20px;"><h1 class="title">Enbrel®<span> (<a href="appendix-112803-W.htm#m340">Wyeth</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Injection</span>, powder for reconstitution,
etanercept, net price 25-mg vial (with solvent) = £89.38. 
    Label:
    10, alert card, counselling, tuberculosis and blood disorders</div><div class="cAY"><span class="cAB">Paediatric injection</span>, powder for
reconstitution, etanercept, net price 25-mg vial (with solvent) =
£89.38. 
    Label:
    10, alert card, counselling, tuberculosis and blood disorders<div class="cAO"><span class="cAG">Excipients </span> include benzyl alcohol (avoid in neonates, see <a title="target-block: Excipients" href="29404.htm#_120000">Excipients</a>)</div></div><div class="cAY"><span class="cAB">Injection</span>, etanercept, net price
25-mg prefilled syringe = £89.38; 50-mg prefilled pen or prefilled
syringe = £178.75. 
    Label:
    10, alert
card, counselling, tuberculosis
and blood disorders</div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="204103.htm">Previous: CERTOLIZUMAB PEGOL</a> | <a class="top" href="128237.htm#">Top</a> | <a accesskey="]" href="212247.htm">Next: GOLIMUMAB</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>